Xovoltib 30 mg

Category:

Xovoltib 30 mg (Afatinib dimaleate) Tablet is working in the treatment of non-small cell lung cancer. It works to treating adult patients who have specific mutations of epidermal growth factor receptor (EGFR).

  • Category : Anti Cancer
  • Manufacturer : Generic
  • Active Substance : Afatinib dimaleate
  • Customer Rate
  • Prescription : Required or Will Provide upon Online Doctor Consultation

INTRODUCTION

XOVOLTIB 30MG TABLET contains Afatinib which belongs to a group of medicines called Kinase inhibitors. XOVOLTIB 30MG TABLET is used as a first line of treatment in patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations (genetic mutation) in cancer cells which can be detected by FDA-approved test.

XOVOLTIB 30MG TABLET is also used to treat metastatic squamous non-small cell lung cancer (NSCLC) in patients who might had some progress with platinum-based chemotherapy (drug therapy used to treat non-small cell lung cancer).

XOVOLTIB 30MG TABLET is not recommended for use if you are allergic to Afatinib. Before taking XOVOLTIB 30MG TABLET, inform your doctor if you have eye, lung, heart, liver, and/or kidney problems.

XOVOLTIB 30MG TABLET is not recommended for use during pregnancy since it may cause harm to the unborn baby.  It is also not recommended for use in breastfeeding women since it may pass though breast milk and cause unwanted side effects in breastfed baby.

XOVOLTIB 30MG TABLET is also not recommended for use in children and adolescents (aged below 18 years).

The most common side effects of taking XOVOLTIB 30MG TABLET are decreased appetite/weight, diarrhea, nausea, vomiting, dry skin, pain/peeling of skin (hands and feet), and/or stomach pain. Contact your doctor if any of the symptoms gets worse.

USES OF XOVOLTIB 30MG TABLET

  • Treats metastatic non-small cell lung cancer (NSCLC) in affected individuals
  • Treats metastatic squamous non-small cell lung cancer which had a limited/insufficient response to platinum-based chemotherapy

HOW XOVOLTIB 30MG TABLET WORKS

XOVOLTIB 30MG TABLET works by blocking the activity of a group of proteins called ErbB1, ErbB2 (HER2), ErbB3 and ErbB4 in the cancer cells which are required for the growth and spread of cancer cells that gets inhibited resulting in the inhibited growth and spread of the cancer cells.

DIRECTIONS FOR USE

Take XOVOLTIB 30MG TABLET as advised by your physician. Swallow XOVOLTIB 30MG TABLET with a glass of water and do not chew or crush the medicine. Your doctor will decide the correct dose and duration of XOVOLTIB 30MG TABLET for you depending upon your age, body weight and disease condition.

SIDE EFFECTS OF XOVOLTIB 30MG TABLET

COMMON

  • Diarrhea
  • Skin reactions such as dry skin, skin rash, itching, lip inflammation
  • Runny nose
  • Dry eye
  • Mouth sores and inflammation
  • Nail infection
  • Reduced desire to eat (decreased appetite)
  • Bleeding from nose
  • Nausea and vomiting
  • Pain, redness, swelling or peeling of skin of your hands and feet
  • Frequent burning sensation during urination, urgent need to urinate (cystitis)
  • Abnormal taste sensation (dysgeusia)
  • Stomach pain, indigestion, heartburn
  • Weight loss
  • Muscle spasms
  • Fever

UNCOMMON

  • Bloating, loss of appetite or sweating due to inflammation of the pancreas (a gland that controls blood sugar level in our body)
  • Severe stomach pain and tenderness due to tear in stomach or intestine

RARE

  • Severe blistering or peeling of the skin

Stop taking XOVOLTIB 30MG TABLET and contact your doctor immediately if you experience any of the following side effects:

  • Diarrhea for more than 2 days or severe diarrhea leading to fluid loss in the body
  • Skin reactions such as redness, rash, and acne
  • Signs of lung or breathing problems due to inflammation of the lungs (trouble breathing or shortness of breath, cough, or fever)
  • Signs of liver problems (yellowing of your skin or the white part of your eyes (jaundice), dark or brown (tea colored) urine, pain on the upper right side of your stomach area (abdomen), bleeding or bruising more easily than normal, feeling very tired)
  • Signs of eye problems (eye pain, swelling, redness, or tearing,  blurred vision, sensitivity to light, other changes in your vision)
  • Signs of heart problems (new or worsening shortness of breath while at rest or with activity, cough, tiredness, swelling of your ankles, feet, or legs (edema), feeling your heart to be pounding or racing (palpitations), sudden weight gain)

HOW TO MANAGE SIDE EFFECTS

Stomach pain:

If XOVOLTIB 30MG TABLET causes stomach pain, then try to take rest and relax and have frequent smaller meals. Drink slowly and try to place a covered hot water bottle on your stomach to ease the pain. If you pain persists then, consult your doctor.

Decreased appetite:

Eat when you feel hungry. Eat smaller meals frequently than usual. Snack only when you’re hungry. Eat a nutritious snack which is rich in calories and protein, such as dried fruit and nuts.

Diarrhoea:

Drink lots of fluids, such as water to keep yourself hydrated. Avoid taking any medicine on your own for treating diarrhea. Consult your doctor if the symptom gets worse.

Nausea and vomiting:

Try to take XOVOLTIB 30MG TABLET with or just after a meal or a snack. Stick to simple meals. Avoid eating rich or spicy food. Consult the doctor if symptoms gets worse.

Indigestion:

Try to have smaller and more frequent meals and eat and drink slowly. Consult your doctor, if symptoms get worse.

Reviews

There are no reviews yet.

Be the first to review “Xovoltib 30 mg”

Your email address will not be published. Required fields are marked *

Xovoltib 30 mg (Afatinib dimaleate) Tablet is working in the treatment of non-small cell lung cancer. It works to treating adult patients who have specific mutations of epidermal growth factor receptor (EGFR).

    Enquiry

    Reviews

    There are no reviews yet.

    Be the first to review “Xovoltib 30 mg”

    Your email address will not be published. Required fields are marked *